ABEONA THERAPEUTICS INC. Cost of Goods Sold (Deprecated 2018-01-31)
ABEONA THERAPEUTICS INC. (ABEO) reported Cost of Goods Sold (Deprecated 2018-01-31) of $0 for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-31.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2015-03-31
- ABEONA THERAPEUTICS INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2014-12-31 was $0.00.
- ABEONA THERAPEUTICS INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- ABEONA THERAPEUTICS INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
- ABEONA THERAPEUTICS INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2014-03-31 was $0.00, a 100.00% decline year-over-year.
- ABEONA THERAPEUTICS INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $0.00, a 100.00% decline from fiscal 2013.
- ABEONA THERAPEUTICS INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2013 was $125.00K, a 53.18% decline from fiscal 2012.
- ABEONA THERAPEUTICS INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2012 was $267.00K, a 80.41% increase from fiscal 2011.
- ABEONA THERAPEUTICS INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2011 was $148.00K, a 5.71% increase from fiscal 2010.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $0.00 derived: sum of 2 quarters · filed 2015-03-31 | $0.00 derived: sum of 3 quarters · filed 2015-03-31 | $0.00 10-K · filed 2015-03-31 | ||||
| 2014-09-30 | $0.00 10-Q · filed 2014-11-14 | $0.00 derived: sum of 2 quarters · filed 2014-11-14 | $0.00 10-Q · filed 2014-11-14 | $0.00 derived: sum of 4 quarters · filed 2015-03-31 | ||||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-14 | $0.00 10-Q · filed 2014-08-14 | $0.00 derived: sum of 3 quarters · filed 2015-03-31 | $7.00K derived: sum of 4 quarters · filed 2015-03-31 | ||||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-12 | $0.00 derived: sum of 2 quarters · filed 2015-03-31 | $7.00K derived: sum of 3 quarters · filed 2015-03-31 | $60.00K derived: sum of 4 quarters · filed 2015-03-31 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $7.00K derived: sum of 2 quarters · filed 2015-03-31 | $60.00K derived: sum of 3 quarters · filed 2015-03-31 | $125.00K 10-K · filed 2015-03-31 | ||||
| 2013-09-30 | $7.00K 10-Q · filed 2014-11-14 | $60.00K derived: sum of 2 quarters · filed 2014-11-14 | $125.00K 10-Q · filed 2014-11-14 | $191.00K derived: sum of 4 quarters · filed 2014-11-14 | ||||
| 2013-06-30 | $53.00K 10-Q · filed 2014-08-14 | $119.00K 10-Q · filed 2014-08-14 | $118.00K 10-Q · filed 2013-08-14 | $184.00K derived: sum of 3 quarters · filed 2014-08-14 | $263.00K derived: sum of 4 quarters · filed 2014-08-14 | |||
| 2013-03-31 | $65.00K 10-Q · filed 2014-05-12 | $131.00K derived: sum of 2 quarters · filed 2014-05-12 | $210.00K derived: sum of 3 quarters · filed 2014-05-12 | $273.00K derived: sum of 4 quarters · filed 2014-05-12 | ||||
| 2012-12-31 | $66.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $145.00K derived: sum of 2 quarters · filed 2014-03-26 | $208.00K derived: sum of 3 quarters · filed 2014-03-26 | $267.00K 10-K · filed 2014-03-26 | ||||
| 2012-09-30 | $79.00K 10-Q · filed 2013-11-14 | $142.00K derived: sum of 2 quarters · filed 2013-11-14 | $201.00K 10-Q · filed 2013-11-14 | $242.00K derived: sum of 4 quarters · filed 2013-11-14 | ||||
| 2012-06-30 | $63.00K 10-Q · filed 2013-08-14 | $122.00K 10-Q · filed 2013-08-14 | $163.00K derived: sum of 3 quarters · filed 2013-08-14 | $224.00K derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2012-03-31 | $59.00K 10-Q · filed 2013-05-15 | $537.00K 10-Q · filed 2012-05-15 | $100.00K derived: sum of 2 quarters · filed 2013-05-15 | $161.00K derived: sum of 3 quarters · filed 2013-05-15 | $198.00K derived: sum of 4 quarters · filed 2013-05-15 | |||
| 2011-12-31 | $41.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-20 | $102.00K derived: sum of 2 quarters · filed 2013-03-20 | $139.00K derived: sum of 3 quarters · filed 2013-03-20 | $148.00K 10-K · filed 2013-03-20 | $1.22M 10-K · filed 2012-03-23 | |||
| 2011-09-30 | $61.00K 10-Q · filed 2012-11-14 | $454.00K 10-Q · filed 2011-11-14 | $98.00K derived: sum of 2 quarters · filed 2012-11-14 | $107.00K 10-Q · filed 2012-11-14 | $812.00K 10-Q · filed 2011-11-14 | $330.00K derived: sum of 4 quarters · filed 2012-11-14 | ||
| 2011-06-30 | $266.00K 10-Q · filed 2011-08-15 | $46.00K 10-Q · filed 2012-08-14 | $358.00K 10-Q · filed 2011-08-15 | $269.00K derived: sum of 3 quarters · filed 2012-08-14 | $269.00K derived: sum of 4 quarters · filed 2012-08-14 | |||
| 2011-03-31 | $92.00K 10-Q · filed 2012-05-15 | $232.00K derived: sum of 2 quarters · filed 2012-05-15 | $232.00K derived: sum of 3 quarters · filed 2012-05-15 | $232.00K derived: sum of 4 quarters · filed 2012-05-15 | ||||
| 2010-12-31 | $140.00K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-23 | $140.00K derived: sum of 2 quarters · filed 2012-03-23 | $140.00K derived: sum of 3 quarters · filed 2012-03-23 | $140.00K 10-K · filed 2012-03-23 | ||||
| 2010-09-30 | $0.00 10-Q · filed 2011-11-14 | $0.00 derived: sum of 2 quarters · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | |||||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-15 | $0.00 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |